FLUTIFORM 50 microgrammes/5 microgrammes par dose, suspension pour inhalation en flacon pressurisé

( ARTG ) FLUTIFORM inhaler is indicated for the regular maintenance treatment of asthma where the use of a combination product (an inhaled corticosteroid and a long-acting beta2-agonist) is appropriate. This includes patients not adequately controlled with inhaled corticosteroids and inhaled short-acting beta2-agonist on an as required basis.